JUPITER, FL, January 23, 2012 – BioRestorative Therapies, Inc. (OTCQB: BRTX) (“BRT”) today announced that it will be presenting at the Seventh International Conference on Cell Therapy for Cardiovascular Disease. The event, being held at the New York-Presbyterian Hospital/Columbia University Medical Center, is a two-and-a-half-day conference dedicated to the evolving field of cell-based therapies for the repair and regeneration of cardiac and vascular disease.
Dr. Amit Patel, Director of Clinical Regenerative Medicine and Tissue Engineering at the University of Utah and a member of the BRT Scientific Advisory Board, will be presenting his findings relating to brown fat stem cells and metabolic disorders (one of BRT’s stem cell initiatives). His talk, entitled “Metabolic Syndrome: A Role For Cell Therapy,” will be on Wednesday, January 25th at 1:50 PM.
Mark Weinreb, Chairman and CEO of BRT, has also been selected to serve on an industry panel and will discuss BRT’s ThermoStem™ Program and the use of brown fat stem cells as potential therapeutics. The session will be held on Thursday, January 26th from 3:15-4:15 PM.
BRT is involved in a research initiative focusing on the use of Brown Fat stem cells to potentially treat metabolic disorders and obesity that may lead to heart disease, diabetes, hypertension, kidney disease and other diseases and disorders.
The Conference will take place January 25-27 at the Vivien and Seymour Milstein Family Heart Center, Myrna L. Daniels Auditorium, NYPH/Columbia University Medical Center, 173 Fort Washington Avenue, First Floor, New York City.